What is the optimal timing for the last dose of Novolog (insulin aspart protamine/insulin aspart) 70/30 when taking Lantus (insulin glargine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of Novolog 70/30 When Using Lantus

When using both Novolog 70/30 and Lantus (insulin glargine), the last dose of Novolog 70/30 should be administered 30 minutes before dinner, with Lantus typically given once daily at bedtime or in the morning. 1

Understanding the Insulin Regimen Components

  • Novolog 70/30 is a premixed insulin containing 30% soluble insulin aspart (rapid-acting) and 70% protamine-crystallized insulin aspart (intermediate-acting) 2
  • Lantus (insulin glargine) is a long-acting basal insulin with no pronounced peak and approximately 24-hour duration 3
  • This combination represents a modified basal-bolus regimen that provides both prandial and basal coverage 3

Optimal Administration Schedule

Novolog 70/30 Administration:

  • Administer twice daily, 30 minutes before breakfast and dinner 1
  • Morning dose: Covers breakfast and provides some basal coverage until lunch/afternoon 3
  • Evening dose: Should be given 30 minutes before dinner to effectively cover the evening meal and provide partial overnight basal coverage 1

Lantus Administration:

  • Administer once daily, either at bedtime or in the morning 3
  • Provides consistent 24-hour basal insulin coverage without pronounced peaks 3
  • Helps maintain stable blood glucose levels between meals and overnight 3

Avoiding Insulin Stacking and Hypoglycemia

  • Important safety consideration: The evening dose of Novolog 70/30 should be timed to avoid insulin stacking with Lantus 3
  • The intermediate-acting component (70% protamine-crystallized insulin aspart) of Novolog 70/30 has a duration of approximately 12 hours 2
  • Administering the evening Novolog 70/30 dose too late (e.g., at bedtime) could lead to overnight hypoglycemia when combined with Lantus 3

Special Considerations

  • For patients with unpredictable eating patterns, postprandial dosing (15-20 minutes after meal onset) may be an acceptable alternative to standard preprandial dosing 4
  • Elderly patients may benefit from this flexibility in dosing time, as it allows them to adjust insulin based on actual food consumption 4
  • For patients on enteral bolus feedings, administer approximately 1 unit of insulin per 10-15g carbohydrate before each feeding 1

Monitoring and Dose Adjustments

  • Monitor blood glucose before meals and at bedtime to assess the effectiveness of the regimen 3
  • If fasting morning glucose levels are consistently elevated despite adequate evening Novolog 70/30 dosing, consider:
    • Adjusting the Lantus dose 3
    • Moving Lantus administration from bedtime to morning 3
  • If postprandial glucose levels remain elevated after dinner, consider:
    • Increasing the evening Novolog 70/30 dose 1
    • Adjusting the ratio of carbohydrates consumed at dinner 1

Alternative Regimens to Consider

  • If glycemic targets are not achieved with twice-daily Novolog 70/30 plus Lantus, consider:
    • Advancing to three-times-daily premixed insulin 3
    • Switching to a full basal-bolus regimen with Lantus plus rapid-acting insulin at each meal 3
    • Adding a GLP-1 receptor agonist if appropriate 3

By following these timing recommendations, patients can optimize glycemic control while minimizing the risk of hypoglycemia when using both Novolog 70/30 and Lantus insulin regimens.

References

Guideline

Novolog 70/30 Dosing Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.